# Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy)

> **NCT02998385** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Groupe Oncologie Radiotherapie Tete et Cou** · enrollment: 342 (estimated)

## Conditions studied

- HNSCC

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT02998385
- **Lead sponsor:** Groupe Oncologie Radiotherapie Tete et Cou
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01-20
- **Primary completion:** 2030-02
- **Final completion:** 2030-03
- **Target enrollment:** 342 (ESTIMATED)
- **Last updated:** 2025-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02998385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02998385, "Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02998385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*